Why Use Conexus With Immuno Modulator CompoundsCoNexus Cancer Centers
CoNexus Care with 21st century immuno-modulating compounds.
CoNexus Care, consists of a unique blend of cancer fighting medicines and immuno-modulating compounds for the treatment of solid tumor cancers.
Each CoNexus Care compound plays a vital role in cancer therapy. CoNexus Care is water-soluble and administered by way of high pressure injection, placing cancer medicines into the tumor and corresponding tumor cells.
A newly discovered oxidant hardens the tumor mass by disturbing existing blood vessels within the tumor, ultimately leading to higher concentration of injected cancer medicines. This hardening of tumor cells, effectively changes the extracellular matrix by altering its morphological and biochemical components, e.g., collagen, elastic fibers, reticular fibers, fibronectin, proteoglycans, hyaluronic acid and other large molecules, eventually “morphing” into a soft, semi-solid state within the tumor.
Another unique feature of CoNexus Care is its ability to avoid administering standard conventional cancer treatment protocols (e.g. Surgery, radiation and/or chemotherapy) in exchange for a minimally-invasive procedure with no side effects, and to benefit from newer immuno-modulator compounds. When multiple autologous tumor antigens are released from the coagulated tumor, cell death can become a "priming" event for T cell response, which then induces potent immunity within the patient's entire body. These cell deaths are called a "good death", which elicit a weak immune response as an in-vivo self-vaccination promoted by an immunologic modulator, i.e., a small molecule haptens. The immuno-modulator reacts within the denatured tumor, causing modified cell debris or matrixes with tumor antigens to produce new and more immuno reactive antigens for better stimulating the host immune system. Therefore, the role of the immuno-modulator is important in enhancing the immunological response to tumor-associated antigens.
Clinical Immuno-therapy Pearls
CoNexus Care Tumor Targeted Immuno-Therapy
* Clinically applied in Germany, Japan and Korea.